Bespoke Extracts (BSPK) Capital Expenditures Growth (1y) (2013 - 2014)
Bespoke Extracts (BSPK) Capital Expenditures Growth (1y) (2013 - 2014) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -21.54% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2014 | 472.00% |
| May 31, 2014 | -88.96% |
| Feb 28, 2014 | -55.20% |
| Nov 30, 2013 | -6.38% |
| May 31, 2013 | 941.67% |